Connect Biopharma Holdings Ltd (CNTB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.52
• Market Cap: $144.79M
• EPS: $-0.89
• 52-Week High: $3.28
• 52-Week Low: $0.51

Market Sentiment

Connect Biopharma Holdings Ltd currently has a Neutral sentiment score of -0.09.

About Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical firm headquartered in Taicang, China, specializing in the discovery and development of innovative immune modulators targeted at severe autoimmune diseases and inflammatory conditions. With a robust pipeline of product candidates, the company is dedicated to addressing significant unmet medical needs, highlighting its potential to deliver breakthrough therapies that improve patient outcomes. By harnessing advanced scienti...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Connect Biopharma Holdings Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CNTB pay dividends?

Connect Biopharma Holdings Ltd (CNTB) does not currently pay a regular dividend.

What is CNTB's market cap?

Connect Biopharma Holdings Ltd (CNTB) has a market capitalization of $144.79M with a current stock price of $2.52.